RGS12 and bipolar disorder: In this way, understanding how the R59Q variation within RGS12, which reduces its PDZ domain’s binding affinity, affects these neurochemical pathways could provide valuable insights into the pathophysiology of bipolar disorder and highlight new therapeutic targets.